Skip to main content
. 2024 Sep 3;15(9):1606–1614. doi: 10.1021/acsmedchemlett.4c00319

Table 1. Preclinical PK and Projected Human PK of Compound GNE-6893.

Species LM CLhepa Hep CLhepa PPBb CL Vss (L/kg) t1/2 (h) %F
Mouse 61 47 94.7 34 1.8 1.7 37
Rat 32 29 90.6 39 2.2 1.3 30
Dogc 19 14 85.8 14 2.2 2.5 46
Cynod 29 9.9 88.4 14 1.9 1.9 53
Human (predicted) 14 5.9 95.5 (5.9) (2.1) (4.1) (43)
a

LM and Hep clearance values (mL/min/kg) represent arithmetic means of two or more determinations.

b

PPB = plasma protein binding (%).

c

Dog PK: Beagle, 0.5 mg/kg i.v. dose or 0.5 mg/kg p.o. dose, plasma clearance measured in mL/min/kg.

d

Cynomolgus Monkey PK: 0.5 mg/kg i.v. dose or 0.5 mg/kg p.o. dose, plasma clearance measured in mL/min/kg.